Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP786027.RA9YXriavrqLv0wLRcX1Z8rjNNKK90mRvFzRbrAotsYqo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP786027.RA9YXriavrqLv0wLRcX1Z8rjNNKK90mRvFzRbrAotsYqo130_assertion type Assertion NP786027.RA9YXriavrqLv0wLRcX1Z8rjNNKK90mRvFzRbrAotsYqo130_head.
- NP786027.RA9YXriavrqLv0wLRcX1Z8rjNNKK90mRvFzRbrAotsYqo130_assertion description "[Our findings offer a preclinical validation of the HIF-1/PDK3 bioenergetic pathway as a new target for therapeutic intervention in metastatic melanoma, opening the door to innovative combinations that might eradicate this disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP786027.RA9YXriavrqLv0wLRcX1Z8rjNNKK90mRvFzRbrAotsYqo130_provenance.
- NP786027.RA9YXriavrqLv0wLRcX1Z8rjNNKK90mRvFzRbrAotsYqo130_assertion evidence source_evidence_literature NP786027.RA9YXriavrqLv0wLRcX1Z8rjNNKK90mRvFzRbrAotsYqo130_provenance.
- NP786027.RA9YXriavrqLv0wLRcX1Z8rjNNKK90mRvFzRbrAotsYqo130_assertion SIO_000772 22865452 NP786027.RA9YXriavrqLv0wLRcX1Z8rjNNKK90mRvFzRbrAotsYqo130_provenance.
- NP786027.RA9YXriavrqLv0wLRcX1Z8rjNNKK90mRvFzRbrAotsYqo130_assertion wasDerivedFrom befree-20140225 NP786027.RA9YXriavrqLv0wLRcX1Z8rjNNKK90mRvFzRbrAotsYqo130_provenance.
- NP786027.RA9YXriavrqLv0wLRcX1Z8rjNNKK90mRvFzRbrAotsYqo130_assertion wasGeneratedBy ECO_0000203 NP786027.RA9YXriavrqLv0wLRcX1Z8rjNNKK90mRvFzRbrAotsYqo130_provenance.